.
MergerLinks Header Logo

Announced

Advanced Instruments to acquire Solentim for £172m.

Financials

Edit Data
Transaction Value£171m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales14x
EV/EBITDA48x
Share Price Premium-
One Off Charge-

Tags

Edit

Cross Border

Pending

Acquisition

Biotechnology

United Kingdom

Majority

Single Bidder

Friendly

biotechnology company

Private

Synopsis

Edit

Advanced Instruments, a manufacturer of analytical instruments and services for bioprocessing, agreed to acquire Solentim, a provider of solutions for the isolation and characterization of high value single cell clones in cell line development applications, for £172m. "The addition of Solentim aligns with our core strategy to invest in leading technologies that deliver significant customer value across different segments in monoclonal antibody and cell and gene therapies," Byron Selman, Advanced Instruments President and CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US